Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Animal Experimentation and Research (1)
- Biology (1)
- Chemicals and Drugs (1)
- Immunology and Infectious Disease (1)
-
- Integrative Biology (1)
- Life Sciences (1)
- Medicinal Chemistry and Pharmaceutics (1)
- Microbiology (1)
- Nanomedicine (1)
- Nanotechnology (1)
- Other Immunology and Infectious Disease (1)
- Pharmaceutical Preparations (1)
- Pharmacology (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Research Methods in Life Sciences (1)
- Therapeutics (1)
- Virology (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Hiv-1 Elimination In Humanized Mice, Hang Su
Hiv-1 Elimination In Humanized Mice, Hang Su
Theses & Dissertations
Human immunodeficiency virus type one (HIV-1) exclusively infects humans and chimpanzees. Therefore, animal models are required for all investigations of viral pathogenesis, therapy and cure. Immunodeficient mice transplanted with human hematopoietic stem cells, termed humanized mice, support the development of multiple human cell lineages throughout the cell’s life span. To this end, we used humanized mice to evaluate the dynamic changes of host immunologic and viral profiles during both acute and chronic HIV-1 infection. We identified the temporal and spatial distribution of HIV-1 cell and tissue compartment infections and outlined correlations made between viral progression and host immunity by comparing …
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Theses & Dissertations
Dolutegravir (DTG) is a potent human immunodeficiency virus type 1 (HIV-1) integrase strand-transfer inhibitor (INSTI) with a high barrier to viral drug resistance. However, opportunities to improve its profile abound. These include extending the drug’s apparent half-life, increasing penetrance to “putative” viral reservoirs, and reducing inherent toxicities. These highlight, in part, the need for long-acting, slow effective release antiretroviral therapy (LASER ART) delivery schemes. A long-acting (LA) DTG was made by synthesizing a hydrophobic and lipophilic prodrug encased with poloxamer (P407) surfactant. This modified DTG (MDTG) reduced systemic metabolism and polarity, increased lipophilicity and membrane permeability, improved encapsulation, and formed …